Human Body & Medicine20 Concepts & Facts

Precision Medicine & Targeted Therapy GK Questions & Answers

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy

Precision medicine represents an innovative paradigm in healthcare that customizes disease prevention, diagnosis, and treatment according to an individual's genetic profile, environmental exposures, and lifestyle habits. Traditional clinical practice has long depended on a standardized, one-size-fits-all model, where therapies are prescribed based on broad population averages. While conventional treatments successfully resolve many acute infections and trauma, they often yield variable responses in complex illnesses such as oncology, autoimmune disorders, and rare metabolic diseases. By decoding how specific molecular variations influence clinical outcomes, precision medicine allows healthcare providers to identify patients who will benefit from targeted interventions while sparing others from ineffective treatments and avoidable adverse events.

The foundation of personalized healthcare rests on high-throughput genomic technologies, molecular diagnostics, and bioinformatics. The completion of the Human Genome Project in 2003 established a reference map of human DNA, accelerating the adoption of Next-Generation Sequencing (NGS). Clinicians analyze genetic markers, cellular transcripts, and metabolic byproducts to pinpoint the biological drivers of disease. In modern oncology, precision oncology employs companion diagnostics to identify somatic mutations such as HER2 overexpression in breast carcinoma, EGFR mutations in non-small cell lung cancer, or BCR-ABL fusions in chronic myeloid leukemia. Instead of deploying broad-spectrum cytotoxic chemotherapy that damages healthy dividing tissues, oncologists administer targeted molecular therapies, including tyrosine kinase inhibitors like imatinib or monoclonal antibodies like trastuzumab, that selectively block oncogenic signaling pathways.

In India, the Department of Biotechnology launched the GenomeIndia Project to build an exhaustive genomic reference catalog reflective of the nation's immense genetic diversity. Completed in 2024, the initiative successfully sequenced ten thousand whole genomes spanning diverse ethnic groups and endogamous populations across the subcontinent. Stored at the Indian Biological Data Centre (IBDC) in Faridabad, these open datasets help researchers discover population-specific disease predispositions, rare monogenic variations, and distinct drug metabolism traits. Complementing clinical oncology, pharmacogenomics investigates how inherited genetic variations in cytochrome P450 enzymes affect drug efficacy and toxicity. As computational tools and artificial intelligence integrate complex omics data, precision medicine continues to transition clinical practice from reactive disease management toward proactive, highly individualized healthcare.

Key Concepts & Self-Assessment20 Key Facts

Review key Precision Medicine & Targeted Therapy exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later

Precision medicine tailors medical care, therapies, and preventive strategies to the individual characteristics of each patient, including genetic profile and environment.

The international Human Genome Project, completed in April 2003, sequenced approximately three billion base pairs, establishing the structural reference for modern human genomics.

Pharmacogenomics analyzes how an individual's genetic makeup affects their bodily response to medications, optimizing drug dosage and minimizing toxicity.

Next-Generation Sequencing (NGS) allows massively parallel sequencing of millions of DNA fragments simultaneously, drastically lowering the cost of whole genome analysis.

In targeted cancer therapy, the drug imatinib acts as a specific tyrosine kinase inhibitor targeting the abnormal BCR-ABL fusion protein in chronic myeloid leukemia.

Monoclonal antibody therapy using trastuzumab selectively binds to human epidermal growth factor receptor 2 (HER2), slowing growth in HER2-positive breast carcinomas.

Companion diagnostics are validated medical assays designed to identify whether a patient will respond favorably to a specific therapeutic prescription.

The Department of Biotechnology in India launched the GenomeIndia Project to create a comprehensive reference grid of the country's diverse population genetics.

In February 2024, the GenomeIndia Project completed the whole-genome sequencing of 10,000 healthy individuals across 99 distinct endogamous communities.

#10

The biological datasets generated by the GenomeIndia Project are archived at the Indian Biological Data Centre (IBDC) located at the Regional Centre for Biotechnology in Faridabad.

#11

Polymorphisms in the Cytochrome P450 (CYP450) family of liver enzymes heavily influence how rapidly individual bodies metabolize common anticoagulants, antidepressants, and statins.

#12

Patients possessing specific CYP2C9 and VKORC1 genetic variants require personalized dosage adjustments of the anticoagulant warfarin to avoid severe hemorrhage.

#13

Testing for the HLA-B*1502 genetic allele is clinically recommended before administering the anticonvulsant carbamazepine in Asian populations to prevent Stevens-Johnson syndrome.

#14

Liquid biopsy is a non-invasive precision medicine technique that isolates and analyzes circulating tumor DNA (ctDNA) from peripheral blood samples.

#15

In non-small cell lung cancer, targeted epidermal growth factor receptor (EGFR) inhibitors such as osimertinib effectively inhibit tumors carrying activating EGFR mutations.

#16

Inherited deleterious mutations in the BRCA1 and BRCA2 tumor suppressor genes significantly elevate lifetime risks of breast and ovarian malignancies.

#17

Poly (ADP-ribose) polymerase (PARP) inhibitors exploit synthetic lethality in tumor cells displaying homologous recombination deficiencies caused by BRCA mutations.

#18

The United States enacted the Genetic Information Nondiscrimination Act (GINA) in 2008 to prevent health insurers and employers from discriminating based on genetic test findings.

#19

Chimeric Antigen Receptor (CAR) T-cell therapy genetically modifies a patient's own autologous T-cells to express synthetic receptors targeting specific cancer antigens.

#20

India approved its first indigenous CAR T-cell therapy, NexCAR19 (actalycabtagene autoleucel), developed by IIT Bombay and Tata Memorial Hospital, in 2023.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight

Precision medicine moves beyond uniform medical protocols by matching therapies directly to a patient's biological characteristics. Instead of assuming that every individual metabolizes pharmaceuticals identically, clinicians examine cellular DNA sequences, disease biomarkers, and lifestyle patterns. By administering custom treatments, such as targeted inhibitors for specific genetic mutations, physicians improve therapeutic outcomes while substantially reducing adverse drug reactions.

In competitive examinations, candidates frequently confuse pharmacogenomics with pharmacovigilance. Pharmacogenomics studies how an individual's genome governs drug response prior to prescription, whereas pharmacovigilance monitors post-marketing drug safety across broad populations. Keep in mind that the GenomeIndia Project sequenced ten thousand individual genomes and archives this information at the Indian Biological Data Centre in Faridabad. For quick exam recall, use the mnemonic "TARGET": Targeted Action Reduces Genetic Errors in Therapy.

Precision Medicine & Targeted Therapy GK Questions & Answers

Key Concepts & Self-Assessment20 Key Facts

Subject Specialist Commentary

Related Knowledge Topics to Discover

Looking for more GK practice?